Ontology highlight
ABSTRACT: Background
The pathology of primary osteoarthritis (OA) begins with structural cartilage damage, which initiates a self-propagating inflammatory pathway that further exacerbates cartilage deterioration. Current standard of care for knee primary OA involves treating the inflammatory symptoms to manage pain, which includes intra-articular (IA) injections of cortisone, an anti-inflammatory steroid, followed by a series of joint-cushioning hyaluronic acid gel injections. However, these injections do not delay the progression of primary OA. More focus on the underlying cellular pathology of OA has prompted researchers to develop treatments targeting the biochemical mechanisms of cartilage degradation.Purpose
Researchers have yet to develop a United States Food and Drug Administr
SUBMITTER: Householder NA
PROVIDER: S-EPMC10150434 | biostudies-literature | 2023 Apr
REPOSITORIES: biostudies-literature